Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Harmony Biosciences Q1 2024 Adj EPS $0.88 Beats $0.62 Estimate, Sales $154.615M Miss $154.796M Estimate

Author: Benzinga Newsdesk | April 30, 2024 07:08am
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.62 by 41.94 percent. This is a 31.34 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $154.615 million which missed the analyst consensus estimate of $154.796 million by 0.12 percent. This is a 29.79 percent increase over sales of $119.126 million the same period last year.

Posted In: HRMY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist